By Editor , 4 November 2026

HANGZHOU – November 04, 2026 -- Minghui Pharmaceutical will receive an upfront payment of USD 110 million from ASKA Pharmaceutical under an exclusive license for MHB018A in Japan, with up to USD 330 million in further milestone payments on offer.

By Editor , 4 November 2026
Hugel Q3 Sales Hit KRW97.5bn as U.S. Shifts to CSO Model

SEOUL – November 04, 2026 -- Hugel Inc. reported third-quarter net sales of KRW97.5 billion, with operating profit of KRW18.1 billion and net profit of KRW4.7 billion, as the South Korean aesthetics group absorbed a short-term hit from restructuring its U.S. sales model. Consolidated net sales for the first three quarters of 2026 totaled KRW352.1 billion, up 15% year-on-year.

By Editor , 4 November 2026
AIIB Members Add $83.5M to Project Preparation Fund

BEIJING – November 04, 2026 -- Members of the Asian Infrastructure Investment Bank (AIIB) have announced USD83.5 million in new commitments to the Bank's Project Preparation Special Fund, lifting total contributions and commitments to about USD213 million.

By Editor , 4 November 2026

Shanghai – November 03, 2026 -- IASO Bio's FUCASO, the first BCMA-targeted CAR-T therapy approved in Singapore, will be covered under the country's Cancer Drug List (CDL) from December 1, 2026. The coverage follows the product's commercial launch in Singapore on November 3 with local partner Pills and Pokes.

By Editor , 4 November 2026
D2 Intelligence's DocuMind Cuts Trade Finance Review to Under 30 Seconds

HONG KONG – November 03, 2026 -- D2 Intelligence, a subsidiary of Wenge AI (1956.HK), reported that its DocuMind platform processed a trade finance document of up to 10 pages in under 30 seconds in the HKMA GenA.I. Sandbox, against 10 to 20 minutes manually. The company presented the result alongside three other AI products at Hong Kong FinTech Week x StartmeupHK 2026, which drew more than 45,000 attendees from more than 120 economies.

By Editor , 4 November 2026
Canton Fair Phase 3 Spotlights Emotional-Value Products

Guangzhou – November 03, 2026 -- Exhibitors in Phase 3 of the 140th Canton Fair pitched products built around fun, companionship and peace of mind, as emotional value becomes a key consumption driver across office supplies, toys and pet categories.

By Editor , 4 November 2026
CStone to Lead Phase I Trials of Kimia's DDR Oncology Asset

SUZHOU – November 03, 2026 -- CStone Pharmaceuticals (HKEX: 2616) will lead Phase I development of Kimia Therapeutics' potential first-in-class DNA damage response (DDR) cancer drug in mainland China and Australia, while Kimia reimburses the applicable clinical development costs.

By Editor , 4 November 2026
Stingray Showcases In-Car Karaoke in BYD Atto 3 at Paris Motor Show

Paris – November 03, 2026 -- Stingray demonstrated its Stingray Karaoke app inside the BYD Atto 3 at the Mondial de l'Auto, extending a partnership with the Chinese automaker that began with the product's first vehicle launch in 2022.

The show was dominated by Chinese and German manufacturers, and Stingray says in-cabin user experience has become a new battleground for consumer loyalty.